A new viewpoint argues exercise belongs on the prescription pad, not the advice pile, as a pillar of brain health care

OTTAWA, Ontario, CANADA, 3 November 2026 — Most of us have heard the advice so often that it has worn smooth, like a stone in a river: get some exercise. A new peer-reviewed Viewpoint in Brain Health, drawing on randomized trials, meta-analyses, and cohort studies, argues that this familiar sentence has been doing the wrong job. Exercise, the authors contend, is not a suggestion to be tossed off at the end of an appointment. It is a treatment. It deserves to be prescribed like one.

The piece comes from Carl Zhou, MD, and Nicholas Fabiano, MD, of the Department of Psychiatry at the University of Ottawa, and Stanley Wong, MD, of the Department of Psychiatry at the University of Toronto. Brain health, they write, means sustaining cognitive, emotional, behavioral, and social functioning across the life course, and exercise touches nearly every one of those domains. Why, then, does clinical practice so often file it under lifestyle chatter?

What moves when the muscles move

What, exactly, happens inside the skull when the legs start working? Brain function, the authors note, depends on sound blood vessels, balanced metabolism, controlled inflammation, and neuroplasticity, and exercise reaches into each. One useful map is the muscle-brain axis: contracting skeletal muscle releases signaling molecules called myokines, which interact with metabolic, inflammatory, neuroendocrine, and neurotrophic pathways tied to mood and cognition. It is one model among several; sleep, vascular risk, and the psychology of mastery and connection matter too.

The historical anchor is a randomized trial in older adults, published in 2011 by Erickson and colleagues, in which aerobic exercise increased the volume of the anterior hippocampus, a region central to memory, and improved memory itself. The Viewpoint adds the caveat a careful reader wants: some of the broader evidence linking activity to sharper cognition and slower brain aging is observational, and should be read that way.

“We still tend to treat exercise as general lifestyle advice,” said Dr. Zhou, the corresponding author. “The evidence we reviewed supports something more deliberate: a prescription that names the type of activity, the frequency, the intensity, the duration, the safety considerations, and a plan for follow-up, just as we would for a medication.”

Where the evidence runs strong, and where it thins

On mood, the synthesis speaks with the most confidence. Across diverse populations, randomized and meta-analytic evidence indicates that physical activity interventions can reduce depressive symptoms, anxiety, psychological distress, and suicide-related outcomes. A 2024 network meta-analysis of randomized trials found that walking, jogging, yoga, and strength training reduced symptoms of depression, with larger effects generally seen at higher intensity.

Then a detail patients may find unexpectedly kind: dose-response analyses suggest that the benefit appears below guideline targets, at roughly half the recommended public-health volume, about 75 minutes a week of moderate activity. For someone who cannot picture the full goal, that is a door left ajar. Could a modest dose that a person actually sustains matter more than an ambitious one that never begins?

For the aging brain, physical activity has been associated with lower risk of cognitive impairment, all-cause dementia, and Alzheimer’s disease, and the World Health Organization includes physical activity in its recommendations for reducing dementia risk. Observational designs, the authors stress, limit causal interpretation.

A neglected population, and a pharmacological question

The Viewpoint gives particular attention to people with schizophrenia and other severe mental illness, who carry high rates of sedentary behavior, cardiometabolic disease, and premature mortality, driven partly by social disadvantage and medication side effects. Meta-analytic evidence suggests that aerobic exercise may improve global cognition in schizophrenia, with possible benefits in working memory, attention, and social cognition. That matters, because cognitive impairment strongly shapes functional outcome and most available drugs do little for it.

“In schizophrenia, exercise can work on psychiatric symptoms, cognition, and physical health at the same time, in a population with substantial unmet needs in all three,” said Dr. Wong. “But the cognition findings rest on a limited set of modest trials, and adequately powered studies are what the field needs next.”

And what of patients who cannot move enough? The muscle-brain model has stirred interest in exercise mimetics, agents that may theoretically reproduce some molecular effects of exercise. The authors draw a firm line: such agents would be an adjunct for people facing major barriers to movement, not a substitute for safe, accessible activity.

Writing the prescription

The World Health Organization recommends 150 to 300 minutes of moderate-intensity aerobic activity per week for adults, or 75 to 150 minutes of vigorous activity, plus muscle strengthening on at least two days. Safety is addressed head on: frailty, unstable cardiac or respiratory symptoms, or recent falls may call for medical assessment, supervision, or a temporary pause. For most patients, the authors favor a graded path, starting low and progressing gradually.

Because depression drains energy and motivation, the first step may be small: a five-minute walk, chair-based exercise, a supervised group, or an activity already woven into the day, such as walking the dog.

“The starting point does not have to be impressive. It has to be possible,” said Dr. Fabiano. “Small, repeated successes build self-efficacy and habit, and that is what creates the conditions for sustained activity.”

Access is part of the dose

The closing argument concerns fairness. Clinicians can screen for activity at routine visits, coordinate with primary care and physiotherapy, and connect patients to community programs. Yet prescribing exercise without addressing access, the authors warn, can widen inequities. Their remedies are concrete: funded community exercise programs, transportation support, and partnerships with recreation and community centers. Who can follow a prescription that they have no way to fill?

The Viewpoint is candid that evidence strength differs across outcomes and study designs. Exercise can be scalable and low cost when access barriers are addressed, and it improves energy, function, sleep, and quality of life. The task, as the authors frame it, is to help each patient find movement that is safe, meaningful, and sustainable. The old advice was never wrong. It was simply unfinished.

The peer-reviewed Viewpoint in Brain Health titled “Exercise is critical for brain health,” is freely available via Open Access, starting on 3 November 2026 in Brain Health at the following hyperlink: https://doi.org/10.61373/bh026v.0027.

The full reference for citation purposes is: Zhou C, Wong S, Fabiano N. Exercise is critical for brain health. Brain Health 2026. DOI: https://doi.org/10.61373/bh026v.0027. Epub 2026 Nov 3.

About Brain Health: Brain Health (ISSN: 3142-9963, online and 3142-9947, print) is a peer-reviewed medical research journal published by Genomic Press, New York, dedicated to the science of lifelong brain resilience. The journal’s scope spans molecular and cellular neuroscience, neuroimaging, electrophysiology, computational modeling, clinical trials, epidemiology, digital health, behavioral intervention science, psychology, normative data, and the social sciences and humanities, organized around the question of how human brains remain resilient, recover when injured, and stay functional across the longest possible arc of a life. Brain Health operates alongside its sister journal Brain Medicine, with the two journals together covering the continuum from disease to resilience.

Visit the Genomic Press Virtual Library: https://issues.genomicpress.com/bookcase/gtvov/

Our media website is at: https://media.genomicpress.com/

Our full website is at: https://genomicpress.com/